Seroprevalence, Risk Factors and Maternal-Fetal Outcomes of Toxoplasma gondii in Pregnant Women from WHO Eastern Mediterranean Region: Systematic Review and Meta-Analysis
- PMID: 37764965
- PMCID: PMC10537388
- DOI: 10.3390/pathogens12091157
Seroprevalence, Risk Factors and Maternal-Fetal Outcomes of Toxoplasma gondii in Pregnant Women from WHO Eastern Mediterranean Region: Systematic Review and Meta-Analysis
Abstract
Background: The protozoan parasite Toxoplasma gondii may cause serious illness in the immunocompromised. The Toxoplasma gondii seropositive prevalence in pregnant women in WHO Eastern Mediterranean Region countries is inconsistent in the literature and it is associated with outcomes that have not be fully elucidated, hence the need for a better understanding of the pooled seroprevalence and associated maternal and fetal outcomes.
Objective: The objective was to conduct a systematic literature review and determine the pooled prevalence of WHO Eastern Mediterranean Regional countries' pregnant women's seroprevalence of Toxoplasma gondii and the maternal-fetal outcomes.
Methods: This quantitative study examined WHO Eastern Mediterranean countries' maternal-fetal outcomes and Toxoplasma gondii prevalence in pregnant women. The targeted population was pregnant women, while the primary outcome was seropositivity of Toxoplasma gondii, while other outcomes such as maternal and fetal associations and risk factors were determined PubMed, SCOPUS, MEDLINE, and Index Medicus for the Eastern Mediterranean Region (IMEMR) databases were searched up until 30 January 2023. The search terms used were "Toxoplasma gondii" OR "Toxoplasma infection" AND "Pregnant woman" or pregnan* OR Antenatal OR Prenatal OR Gravidity OR Parturition OR Maternal AND WHO Eastern Mediterranean Region). OpenMeta-Analyst and Jamovi were used to analyze the generated data.
Results: In total, 95 of 2947 articles meeting the inclusion criteria examined Toxoplasma gondii prevalence in pregnant women from WHO Eastern Mediterranean countries. The pooled prevalence of Toxoplasma gondii in pregnant women was 36.5% (95%CI: 32.6-40.4) with a median value of 35.64%, range values of 1.38-75.30%, with 99.61% heterogeneity. The pooled seroprevalence of IgG of Toxoplasma gondii was 33.5% (95%CI: 29.8-37.2) with a median value of 33.51%, and a range values of 1.38-69.92%; the pooled seroprevalence of IgM was 3.6% (95%CI: 3.1-4.1)) with a median value of 3.62 and range values of 0.20-17.47%, while cases of pooled seroprevalence of both IgG and IgM positivity was 3.0% (95%CI: 1.9-4.4) with a median value of 2.05 and a range values of 0.05-16.62%. Of the Toxoplasma gondii seropositive women, 1281/3389 (34.8%) 174/1765 (32.9%), 1311/3101 (43.7%), and 715/1683 (40.8%) of them had contact with cats, drank unprocessed milk, ate raw or undercooked meat and ate unwashed raw vegetables, respectively. The maternal-fetal outcomes associated with Toxoplasma gondii seropositivity were a history of abortions, miscarriage, stillbirth, intrauterine fetal death, and premature birth, which were found in 868/2990 (32.5%), 112/300 (36.1%), 111/375 (25.7%), 3/157 (1.9%) and 96/362 (20.1%) of women who tested positive for Toxoplasma gondii antibodies.
Conclusion: The study found a high proportion of Toxoplasma gondii seroprevalence in pregnant women in the WHO Eastern Mediterranean Region, which may be linked to poor outcomes for mothers and their babies. Thus, pregnant women require monitoring and comprehensive prevention strategies for Toxoplasma gondii infection.
Keywords: Eastern Mediterranean; Toxoplasma gondii; miscarriage; pregnancy; stillbirth.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.BMC Res Notes. 2016 Aug 15;9(1):406. doi: 10.1186/s13104-016-2206-0. BMC Res Notes. 2016. PMID: 27528009 Free PMC article.
-
Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2024 May 23;18(5):e0012198. doi: 10.1371/journal.pntd.0012198. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38781272 Free PMC article.
-
Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.BMC Infect Dis. 2019 Dec 30;19(1):1089. doi: 10.1186/s12879-019-4718-4. BMC Infect Dis. 2019. PMID: 31888517 Free PMC article.
-
Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China.Microb Pathog. 2018 Oct;123:398-401. doi: 10.1016/j.micpath.2018.07.041. Epub 2018 Jul 29. Microb Pathog. 2018. PMID: 30063975
-
Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis.Sci Rep. 2020 Jul 21;10(1):12102. doi: 10.1038/s41598-020-69078-9. Sci Rep. 2020. PMID: 32694844 Free PMC article.
Cited by
-
Prevalence of Toxoplasma gondii antibodies among waste collectors in Kuwait.Parasite Epidemiol Control. 2025 May 29;30:e00431. doi: 10.1016/j.parepi.2025.e00431. eCollection 2025 Aug. Parasite Epidemiol Control. 2025. PMID: 40585949 Free PMC article.
References
-
- Bigna J.J., Tochie J.N., Tounouga D.N., Bekolo A.O., Ymele N.S., Youda E.L., Sime P.S., Nansseu J.R. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: A systematic review, modelling and meta-analysis. Sci. Rep. 2020;10:12102. doi: 10.1038/s41598-020-69078-9. - DOI - PMC - PubMed
-
- Mahmood M.T., Kahya H.F.H. Serological study of torch complex in pregnant women with an obstetric history in mosul city, iraq. Curr. Trends. Immunol. 2021;22:95–102. doi: 10.31300/CTIMM.22.2021.95-102. - DOI
-
- Elamin M.H., Al-Olayan E.M., Omer S.A., Alagaili A.N., Mohammed O.B. Molecular detection and prevalence of Toxoplasma gondii in pregnant women in Sudan. African J. Microbiol. Res. 2012;6:308–311.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous